Cargando…
Mirogabalin as a Novel Gabapentinoid for the Treatment of Chronic Pain Conditions: An Analysis of Current Evidence
Neuropathic pain is a challenge for physicians to treat and often requires a multimodal approach with both pharmacologic and lifestyle interventions. Mirogabalin, a potent, selective ligand of the α2δ-1 and α2δ-2 subunits of voltage-gated calcium channels (VGCCs), provides analgesia by inhibiting ne...
Autores principales: | Chen, Eric Y., Beutler, Sascha S., Kaye, Alan D., Edinoff, Amber N., Khademi, Seyed-Hossein, Stoltz, Andrea E., Rueb, Nicole R., Cornett, Elyse M., Suh, Winston J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Briefland
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909537/ https://www.ncbi.nlm.nih.gov/pubmed/35291398 http://dx.doi.org/10.5812/aapm.121402 |
Ejemplares similares
-
Mirogabalin, a selective gabapentinoid for managing neuropathic pain—A curtain raiser
por: Nair, Abhijit
Publicado: (2022) -
The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids
por: Tang, Hui, et al.
Publicado: (2023) -
Burst Spinal Cord Stimulation in the Management of Chronic Pain: Current Perspectives
por: Edinoff, Amber N., et al.
Publicado: (2022) -
Updated Perspectives on the Neurobiology of Substance Use Disorders Using Neuroimaging
por: Murnane, Kevin S, et al.
Publicado: (2023) -
Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
por: McAnally, Heath, et al.
Publicado: (2020)